Rankings

Market Cap
Revenue
Operating Income
CapEx
Total Assets
Net Assets
Cash on Hand

Sectors

Technology
Healthcare
Financial Services
Consumer Cyclical
Communication Services
Industrials
Consumer Defensive
Energy
Basic Materials
Real Estate
Utilities

Pages

Home
Earnings Calendar
All Sectors
Terms
Privacy

© 2026 Market Cap Arena. All rights reserved.v1.2.29

CSTL FY 2017 Earnings — Castle Biosciences, Inc. Revenue & Financial Results | Market Cap Arena

CSTLCastle Biosciences, Inc.

$772M

FY 2017 Earnings

Healthcare Medical - Diagnostics & Research

Income Statement

Revenue

$14M

Gross Profit

$9M64.2% margin

Operating Income

-$11M-79.2% margin

Net Income

-$12M-89.9% margin

EPS (Diluted)

$-1.26

Cash Flow

Operating Cash Flow

-$12M

Free Cash Flow

-$13M

Stock-Based Comp.

$108,696

Balance Sheet

Total Assets

$10M

Total Liabilities

$24M

Stockholders' Equity

-$14M

Cash & Equivalents

$1M

← Q1 2018 All Quarters